Press Kit
Sandoz, the generic pharmaceuticals division of Novartis, is a global leader in the rapidly growing generics industry. The company offers a broad portfolio of approximately 1 000 high-quality, affordable molecules across all major therapeutic areas and approximately 130 countries, and is a global leader in differentiated products. Today, Sandoz is one of the two largest global generic companies, with leading positions across the largest pharmaceutical markets worldwide.Downloads:
The press kit reflects information and data that is current and factual as at the date of publication.
